scholarly journals Diagnostic and prognostic role of serum Ki-67 and HE4 levels in Egyptian breast cancer patients

2021 ◽  
Vol 17 (1) ◽  
pp. 9-21
Author(s):  
Al-Shimaa M. Abas ◽  
Mohamed H Sherif ◽  
Sara A. Elmoneam Farag
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Prognostic Role ◽  
Ki 67

scholarly journals Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients

2020 ◽  
Vol 23 (2) ◽  
pp. 182 ◽  
Author(s):  
Yaewon Yang ◽  
Ahrum Min ◽  
Kyung-Hun Lee ◽  
Han Suk Ryu ◽  
Tae-Yong Kim ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Androgen Receptor ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Receptor Expression ◽  
Androgen Receptor Expression ◽  
Breast Cancer Patients ◽  
Prognostic Role

scholarly journals Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients

2019 ◽  
Vol 51 (1) ◽  
pp. 128-140 ◽  
Author(s):  
Ling Deng ◽  
Xuehua Zhu ◽  
Yun Sun ◽  
Jiemin Wang ◽  
Xiaorong Zhong ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Prognostic Role

Independent validation of stromal uPA in archived tumor samples from the prospectively randomized ABCSG8 trial to provide level 1b evidence for a prognostic value of uPA immunohistochemistry in endocrine-treated postmenopausal breast cancer patients.

2017 ◽  
Vol 35 (15_suppl) ◽  
pp. 536-536
Author(s):  
Christian F. Singer ◽  
Stephan W Jahn ◽  
Margaretha Rudas ◽  
Zsuzsanna Bago-Horvath ◽  
Florian Fitzal ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Early Breast Cancer ◽  
Hormone Receptor ◽  
Prognostic Value ◽  
Breast Cancer Patients ◽  
Prognostic Role ◽  
Hormone Receptor Positive ◽  
Pai 1

536 Background: We have recently demonstrated that urokinase Plasminogen Activator (uPA), together with its inhibitor PAI-1, have prognostic value in hormone-receptor positive early breast cancer, and can be measured in FFPE archived tumor samples. We have now aimed to validate the prognostic role of uPA protein expression in FFPE archived tumor samples in an independent cohort of endocrine-treated breast cancer patients. Methods: 303 postmenopausal women with hormone receptor–positive, early breast cancer who had received 5 years of endocrine therapy in the prospectively designed ABCSG-08 trial, and in whom FFPE tumor tissue was available, were included in this analysis. Stromal uPA and PAI-1 protein expression was evaluated by immunohistochemistry and correlated with distant recurrence-free survival (DRFS) and overall survival (OS). Results: Stromal uPA was detected in 132 of 297 tumors (44.4%), and 74 out of 269 samples (27.5%) exhibited stromal PAI-1, while co-expression of both proteins was found in 48 of 294 (16.3%) samples. Neither uPA nor PAI-1 expression were associated with tumor size, age, nodal status, grading, or receptor status. Patients whose tumor stroma expressed uPA protein were more likely to have a shorter DRFS (adjusted HR for relapse: 2.78; 95% CI 1.31-5.93; p=0.008 Cox regression analysis) and OS (adjusted HR for death: 1.29; 95% CI 0.86-12.50; p=0.161) than women without uPA expression. No such association was observed for PAI-1 and for the uPA/PAI1 ratio. After a median follow-up of 5.6 years women with uPA-positive tumors experienced a significantly shorter DRFS (93.3% vs 84.8%; p<0.013 log rank test) and tended to have a worse OS (83.0.4% vs 77.3%; p=0.106) compared to women with uPA negative tumors. Conclusions: By confirming the clinical utility of stromal uPA IHC in archived breast cancer samples from an independent prospective randomized trial, we now provide level 1b evidence for a prognostic role of stromal uPA in women with endocrine-responsive early breast cancer.

scholarly journals Prognostic Role of PTEN Gene Expression and Length of Survival of Breast Cancer Patients in the North East of Iran

2016 ◽  
Vol 17 (sup3) ◽  
pp. 305-309 ◽  
Author(s):  
Rahim Golmohammadi ◽  
Mohammad Hassan Rakhshani ◽  
Ali Reza Moslem ◽  
Akbar Pejhan
Keyword(s):  
Breast Cancer ◽  
Gene Expression ◽  
Cancer Patients ◽  
Pten Gene ◽  
Breast Cancer Patients ◽  
Prognostic Role ◽  
North East ◽  
The North ◽  
East Of Iran

Prognostic Role of Platelets-to-Lymphocytes Ratio and Neutrophils-to-Lymphocytes Ratio in Breast Cancer Patients

2019 ◽  
Vol 105 (1) ◽  
pp. E32-E33
Author(s):  
I.R. Scognamiglio ◽  
M. Conson ◽  
M. Caroprese ◽  
A. Romano ◽  
A. Farella ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Prognostic Role

scholarly journals Prognostic role of high neutrophil-to-lymphocyte ratio in breast cancer patients receiving neoadjuvant chemotherapy

Medicine ◽  
2019 ◽  
Vol 98 (1) ◽  
pp. e13842 ◽  
Author(s):  
Ling Bo Xue ◽  
Yong Hong Liu ◽  
Bo Zhang ◽  
Yan Fang Yang ◽  
Dong Yang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Cancer Patients ◽  
Neutrophil To Lymphocyte Ratio ◽  
Breast Cancer Patients ◽  
Prognostic Role ◽  
Lymphocyte Ratio

scholarly journals Prognostic role of c-met expression in breast cancer patients

2011 ◽  
Vol 16 (5) ◽  
pp. 173-177 ◽  
Author(s):  
Iwona Gisterek ◽  
Ewelina Lata ◽  
Agnieszka Halon ◽  
Rafal Matkowski ◽  
Jolanta Szelachowska ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Prognostic Role

scholarly journals P186 Prognostic role of VEGFR1–3 immunoreactivity in breast cancer patients

The Breast ◽  
2011 ◽  
Vol 20 ◽  
pp. S40
Author(s):  
I.J. Gisterek ◽  
A. Halon ◽  
U. Staszek-Szewczyk ◽  
R. Matkowski ◽  
J. Szelachowska ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Prognostic Role
Sign in / Sign up

Export Citation Format

Share Document